Vir Biotechnology - San Francisco, Calif., 7.1 million shares, priced $20-$22, managed by Goldman Sachs/JP Morgan. Proposed Nasdaq symbol VIR.
News
- Initial public offerings scheduled to debut next week
- Son of ex-US Rep. Chris Collins pleads guilty in stock fraud
... 69-year-old Collins stemmed from his business dealings with Innate Immunotherapeutics Ltd., a biotechnology company headquartered in Australia.
- City Council Approves Sale of Buildings in St. Paul Square
San Antonio City Council approved on Thursday the sale of five properties it owned in the St. Paul Square Historic District for nearly $1.76 million.
- Alamo Colleges launches free tuition program
They are making sure that no one will be precluded from getting an education because we know that if San Antonio doesn't have a high-skilled ...
- FDA Updates Neratinib Label in HER2+ Breast Cancer
Puma Biotechnology. Published ... Presented at: 2017 San Antonio Breast Cancer Symposium; December 5-9, 2017; San Antonio, TX. Abstract ...